High-Risk Acute Promyelocytic Leukemia with Unusual T/Myeloid Immunophenotype Successfully Treated with ATRA and Arsenic Trioxide-Based Regimen.

Singh, Zeba N; Duong, Vu H; Koka, Rima; Zou, Ying; Sawhney, Sameer; Tang, Li; Baer, Maria R; Ambulos, Nicholas; El Chaer, Firas; Emadi, Ashkan

Singh, Zeba N; Duong, Vu H; Koka, Rima; Zou, Ying; Sawhney, Sameer; Tang, Li; Baer, Maria R; Ambulos, Nicholas; El Chaer, Firas; Emadi, Ashkan.

Afiliação

Singh ZN; Department of Pathology, University of Maryland School of Medicine.
Duong VH; Department of Medicine, University of Maryland School of Medicine.
Koka R; University of Maryland Greenebaum Comprehensive Cancer Center Baltimore, MD, USA.
Zou Y; Department of Pathology, University of Maryland School of Medicine.
Sawhney S; Department of Pathology, University of Maryland School of Medicine.
Tang L; Department of Pathology, University of Maryland School of Medicine.
Baer MR; University of Maryland Greenebaum Comprehensive Cancer Center Baltimore, MD, USA.
Ambulos N; Department of Medicine, University of Maryland School of Medicine.
El Chaer F; University of Maryland Greenebaum Comprehensive Cancer Center Baltimore, MD, USA.
Emadi A; University of Maryland Greenebaum Comprehensive Cancer Center Baltimore, MD, USA.

J Hematop ; 11(3): 67-74, 2018 09.

Article em En | MEDLINE | ID: mdl-30294391

Palavras-chave

acute promyelocytic leukemia (APL); all-trans retinoic acid (ATRA); arsenic trioxide (ATO); measurable (minimal) residual disease (MRD); mixed phenotype acute leukemia (MPAL)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: J Hematop Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google